Prestige Consumer Healthcare Inc (PBH)
Prestige Consumer Healthcare Inc. is a U.S.-listed common equity on the NYSE in the healthcare sector. Through its subsidiaries, the company develops, manufactures, markets, distributes, and sells over-the-counter health and personal care products across North America, Australia, and other international markets. Its portfolio includes branded products used for pain relief, diaper rash care, throat and mouth discomfort, eye care, wart removal, ear wax removal, dental hygiene, motion sickness, laxative and digestive relief, cough drops, yeast infection treatment, lice and parasite treatment, feminine care, dry eye relief, nasal saline products, and oral rehydration. Sales are made through mass merchandisers, drug and food stores, dollar and convenience outlets, club channels, and e-commerce. The company was founded in 1996, is based in Tarrytown, New York, and adopted its current name in August 2018.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-PBH
|
$69.82
|
41.1% Upside
|
Undervalued
|
$66.80
|
35.0% Upside
|
Undervalued
|
Great
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
12.4x
|
1.3x
|
2.2x
|
2.388 B
|
3.343 B
|
30.4%
|
98.6%
|
8.9
|
—
|
129.5%
|